Skip to main content

Pfizer deal will help expand reach of migraine pill Nurtec, Biohaven CEO says

"We have to bring the modern day, novel therapies to those patients, and Pfizer really is the best company to build upon our work," Coric said.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.